Abstract
Digital proxies of human mobility and physical mixing have been used to monitor viral transmissibility and effectiveness of social distancing interventions in the ongoing COVID-19 pandemic. We developed a new framework that parameterizes disease transmission models with age-specific digital mobility data. By fitting the model to case data in Hong Kong, we were able to accurately track the local effective reproduction number of COVID-19 in near real time (i.e. no longer constrained by the delay of around 9 days between infection and reporting of cases) which is essential for quick assessment of the effectiveness of interventions on reducing transmissibility. Our findings showed that accurate nowcast and forecast of COVID-19 epidemics can be obtained by integrating valid digital proxies of physical mixing into conventional epidemic models.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by a commissioned grant from the Health and Medical Research Fund from the Government of the Hong Kong Special Administrative Region. The funding bodies had no role in study design, data collection and analysis, preparation of the manuscript, or the decision to publish.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The analysis was based on the line list of reported COVID-19 cases in Hong Kong. https://www.chp.gov.hk/files/pdf/local_situation_covid19_en.pdf Ethical approval is waived by the Institutional Review Board of The University of Hong Kong/Hospital Authority Hong Kong West Cluster (HKU/HA HKW IRB).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We collated epidemiological data from publicly available data sources (https://www.coronavirus.gov.hk/eng/index.html and https://data.gov.hk/en-data/dataset/hk-dh-chpsebcddr-novel-infectious-agent). All the epidemiological information that we used is available in the main text or the supplementary materials. The aggregate data of passenger number by card types (i.e. child, student, adult and elder), the aggregate data of passenger number by public transportation means and the aggregate data of transactions by retail categories were provided by Octopus Cards Limited (Octopus). Our agreement with Octopus prohibits us from further sharing data with third parties but interested parties can contact Octopus to make the same data request.
